期刊文献+

2型糖尿病患者血浆D-二聚体的变化与血液流变和血脂的关系 被引量:2

The change of plasma D-dimer levels and its relation to hemorrheology and blood lipids in patients with NIDDM
下载PDF
导出
摘要 目的 :为探讨 2型糖尿病 (DM )患者凝血及纤溶活性与血液流变学的关系 ,方法 :采用ELISHA法测定了 6 5例 2型DM患者和 30名正常对照的血浆D -二聚体水平 ,同时测定血粘度和血脂。结果 :显示 2型DM患者血浆D -二聚体 ,血粘度 ,总胆固醇和甘油三脂水平显著高于正常对照组 (P <0 .0 1) ,伴有视网膜病变 2型DM组的血浆D -二聚体 ,全血粘度 ,血浆粘度 ,红细胞聚积指数和变形指数均高于无视网膜病变组 (P <0 .0 1) ;血浆D -二聚体水平与空腹血糖 ,全血粘度低切率和血浆粘度呈正相关 (P <0 .0 1)。结论 :提示 2型DM患者存在血凝和纤溶活性增高 ,并与血液流变学改变密切相关 ;血浆D -二聚体是监测 Objective: In order to investingate the coagulability and fibrinolysis and its relation to hemorrheological alterations in the NIDDM patients. Methods: The plasma concentrations of D-dimer in 65 NIDDM patients and 30 healthy subjects were determined by using a sandwich ELISA; blood viscosity and serum lipids were measured simultaneously. Results: The results showed that the levels of D-dimer ,blood viscosity, cholesterol and triglyceride in NIDDM patients were significantly higher than those in healthy subjects (P<0.01) .There was significantly higher level of plasma D-dimer and indexes of hemorrheology in diabetics with retinopathy than in diabetics without retinopathy(P<0.01). The level of D-dimer was correlated positively with low shear of blood viscosity, plasma viscosity and fasting blood glucose in NIDDM patients (P<0.01) .Conclusion: The above findings indicate that in NIDDM patients, there are increases in coagulability and fibrinolysis, which are closely related to alterations of hemorrheology.Plasma D-dimer is useful for monitoring coagulation and fibinolysis in NIDDM patients .
出处 《重庆医科大学学报》 CAS CSCD 2000年第2期140-141,150,共3页 Journal of Chongqing Medical University
关键词 Ⅱ型糖尿病 D-二聚体 血液流变学 血脂 Diabetes D-dimer Hemorrheology
  • 相关文献

参考文献14

二级参考文献99

  • 1余慧,金润铭,白燕,林雯.急性淋巴细胞白血病患儿亚甲基四氢叶酸还原酶多态性与氨甲蝶呤毒副反应的研究[J].中华儿科杂志,2005,43(4):302-303. 被引量:26
  • 2顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:476
  • 3韦润红,赵国兴,陈疏敏,程志.大剂量甲氨蝶呤治疗儿童急性淋巴细胞白血病耐受性临床研究[J].儿科药学杂志,2006,12(3):12-14. 被引量:18
  • 4Frosst P, Blom HJ, Milos R,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995, 10 (1) : 111-113.
  • 5Ghodke Y, Chopra A, Joshi K, et al. Are thymidylate synthase and methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients? Clin Rheumatol, 2008, 27 (6) : 787-789.
  • 6Fisher MC, Cronstein BN. Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. J Rheumatol, 2009,36 (3) : 539-545.
  • 7Karas Kuzelicki N, Milek M, Jazbec J, et al. 5,10- methylenetetrahydrofolate reductase (MTHFR) low activity genotypes reduce the risk of relapse-related acute lymphoblastic leukemia(ALL). Leuk Res,2009,33(10) : 1344-1348.
  • 8Krull KR, Brouwers P, Jain N, et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr, 2008,152 ( 1 ) : 101-105.
  • 9Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood, 2004,103 ( 1 ) :252-257.
  • 10Alcasabas P, Ravindranath Y, Goyette G, et al. 5, 10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children. Pediatr Blood Cancer, 2008,51 ( 2 ) : 178-182.

共引文献437

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部